|
|
|
«
1-A
B
C-D
E-G
H-L
M
N-O
P
Q-R
S
T-U
V-Z
»
«
MASA
Mont »
|
 |
|
|
MASA Life Science Ventures (MLSV)
Offices: Washington, DC & Tokyo, Japan
MASA Life Science Ventures is a venture
capital fund focused on adding real value
to the best of private, high-growth biotechnology
and life science companies. MLSV's investors
include several of Japan and Korea's leading
corporations and financial institutions.
These investors help provide an important
bridge to key markets in East Asia. MLSV’s
team of investment professionals have broad
experience in the biotech, pharmaceutical,
medical device and healthcare industries. |
Mayo Medical Ventures (MMV)
Offices: Rochester, New York
Mayo Medical Ventures, which is a division
of Mayo Foundation for Medical Education
and Research, was started in 1986 as a response
to ever-tightening reimbursement for patient
care services. MMV's charge is to generate
new sources of revenue to support Mayo's
clinical practice, medical education and
medical research activities. Technology
Based Ventures (TBV) allow Mayo to consider
internal technologies as the basis for the
formation of new medically related start-up
companies. Mayo will invest its own funds
in these companies when certain clearly
defined criteria are met. |
Medica Venture Partners
Offices: Herzliya, Israel & Boston,
Massachusetts
Medica Venture Partners is a globally operating
health care and life sciences venture capital
fund investing in Israel, Europe and the
United States providing equity financing,
management assistance and expertise to early
stage startups and seed stage companies
in all areas of health care and life science
technologies; from medical devices to pharmaceuticals,
biotech and genomics. Medica co-invests
with some of the top health care funds in
the world and has an extensive and unique
operational base and infrastructure in Israel. |
MedImmune Ventures
Offices: Gaithersburg, Maryland
MedImmune Ventures is a wholly owned venture
capital fund within the AstraZeneca/MedImmune
group of companies. It was created in 2002
to leverage MedImmune's expertise in discovering,
developing and commercializing biotechnology
products, as well as its financial resources,
to transform new ideas in biotechnology
into successful products and companies.
They invest in early- to late-stage, public
or private biotechnology companies focused
on discovering and developing human therapeutics. |
|
|
Mediphase Venture Partners
Offices: Newton, Massachusetts
Mediphase Venture Partners is a venture
capital firm focusing on early stage companies
in life sciences/health care. They seek
rapidly growing companies with outstanding
market opportunities. They are active investors,
usually joining the Boards of their portfolio
companies and working closely with management
to promote rapid growth. The fund managers
bring an unusual combination of technical
experience, operating experience, and investment
experience, which can be critical to the
success of an early stage company. |
MedVentures Associates (MVA)
Offices: Emeryville, California
The members of the team at MedVenture Associates
have precisely selected the areas they wish
to pursue for investment opportunities.
The MVA Team has vast experience in the
fields of medical technology, including
medical devices, instrumentation and medical
diagnostic technology, medical information
technology, healthcare services, biotechnology,
and pharmaceutical products, and selected
later stage investments. Investments will
be made in these areas where the goal is
to create significant, substantial new businesses. |
Merlin BioMed Group
Offices: New York, New York
The Merlin Nexus Funds invest in growth
segments of the healthcare industry, with
an emphasis on product-driven life sciences
companies developing breakthrough therapeutics
for clinical needs, positively altering
disease course and associated costs. Their
funds distinguish themselves from traditional
healthcare or life science venture funds
by the relatively high liquidity of their
investments and by the short 5-year maturity
of their funds. They target for each private
investment, a potential for liquidity within
24 months after initial investment, as well
as a 2-3 times return on invested capital. |
Mithra Group
Offices: Boston, Massachusetts
Founded in 2004, Mithra Group focuses on
life science investing opportunities in
the United States and India. Mithra Group
recently raised its first fund of $100M.
Their investment strategy is predicated
on the belief that in the same way that
there is no blueprint for how a company
builds value, there is also no single formula
for the role of an investor in helping it
to do so. They bring the creativity to look
at each company uniquely, and the flexibility
as an organization to tailor the size and
structure of their investment to the needs
of the particular opportunity. |
| |
|
|
|
|
|
Bio Life (Montreux)
Resources
to
top